Relmada Therapeutics, Inc. RLMD Excess tax benefits associated with employee equity plans
Excess tax benefits associated with employee equity plans at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount.
The official record: Relmada Therapeutics, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s excess tax benefits associated with employee equity plans.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s excess tax benefits associated with employee equity plans?
- Relmada Therapeutics, Inc. (RLMD) reported excess tax benefits associated with employee equity plans of $2.22M in Q4 2025.
- What does excess tax benefits associated with employee equity plans mean?
- This represents the dollar value of tax benefits realized from share-based compensation awards that exceed the initial book expense. It reflects the positive tax impact of equity incentives when stock prices perform well.